Skip to main content

Table 1 Demographics of study population according to kidney function

From: The impact on incident tuberculosis by kidney function impairment status: analysis of severity relationship

Variables

CKD

Long term dialysis (n = 1579)

Kidney transplant (n = 38)

P-value

nil or stage 1 (n = 129,421)

2 (n = 128,248)

3a (n = 17,228)

3b (n = 7116)

4 (n = 3449)

5 (n = 2500)

Age (years)

43.8 ± 15.2

55.5 ± 15.7

69.5 ± 12.4

71.6 ± 12.8

70.1 ± 14.2

62.7 ± 15.1

56.9 ± 14.4

54.8 ± 11.7

< 0.0001

Age group

< 0.0001

 ≤ 40

57,461 (44.4)

23,076 (18.0)

409 (2.4)

151 (2.1)

141 (4.1)

226 (9.0)

204 (12.9)

5 (13.2)

 

 40–55

38,907 (30.1)

35,828 (27.9)

1744 (10.1)

613 (8.6)

380 (11.0)

514 (20.6)

499 (31.6)

12 (31.6)

 

 55–65

21,780 (16.8)

31,925 (24.9)

3430 (19.9)

1175 (16.5)

537 (15.6)

586 (23.4)

404 (25.6)

14 (36.8)

 

 > 65

11,273 (8.7)

37,419 (29.2)

11,645 (67.6)

5177 (72.8)

2391 (69.3)

1174 (47.0)

472 (29.9)

7 (18.4)

 

Male gender

51,354 (39.7)

63,394 (49.4)

8942 (51.9)

3582 (50.3)

1738 (50.4)

1304 (52.2)

804 (50.9)

27 (71.1)

< 0.0001

Serum Creatinine

0.7 ± 0.1

0.9 ± 0.2

1.2 ± 0.2

1.7 ± 0.3

2.6 ± 0.6

6.8 ± 3.0

7.2 ± 3.2

2.6 ± 2.2

<0.0001

eGFR

108.2 ± 18.2

77.6 ± 8.0

53.8 ± 4.2

38.5 ± 4.3

23.3 ± 4.3

9.0 ± 3.3

11.4 ± 12.9

47.9 ± 31.9

< 0.0001

COPD

767 (0.6)

1512 (1.2)

491 (2.9)

231 (3.3)

92 (2.7)

44 (1.8)

10 (0.6)

1 (2.6)

< 0.0001

Asthma

1320 (1.0)

1566 (1.2)

285 (1.7)

117 (1.6)

35 (1.0)

20 (0.8)

11 (0.7)

0 (0.0)

< 0.0001

Bronchiectasis

389 (0.3)

415 (0.3)

53 (0.3)

24 (0.3)

12 (0.4)

5 (0.2)

0 (0.0)

0 (0.0)

0.3808

Pneumoconiosis

34 (0.0)

48 (0.0)

13 (0.1)

6 (0.1)

1 (0.0)

0 (0.0)

3 (0.2)

0 (0.0)

NA

IPF

182 (0.1)

178 (0.1)

32 (0.2)

10 (0.1)

9 (0.3)

6 (0.2)

1 (0.1)

0 (0.0)

NA

GERD

4119 (3.2)

5036 (3.9)

630 (3.7)

228 (3.2)

101 (2.9)

79 (3.2)

47 (3.0)

0 (0.0)

< 0.0001

Obesity

891 (0.7)

685 (0.5)

40 (0.2)

13 (0.2)

14 (0.4)

7 (0.3)

1 (0.1)

0 (0.0)

< 0.0001

Cancer

14,895 (11.5)

16,417 (12.8)

2964 (17.2)

1382 (19.4)

645 (18.7)

270 (10.8)

197 (12.5)

5 (13.2)

< 0.0001

Cirrhosis

1314 (1.0)

1509 (1.2)

400 (2.3)

236 (3.3)

132 (3.8)

46 (1.8)

37 (2.3)

1 (2.6)

< 0.0001

CHF

662 (0.5)

1543 (1.2)

709 (4.1)

501 (7.0)

348 (10.1)

231 (9.2)

96 (6.1)

1 (2.6)

< 0.0001

Stroke

763 (0.6)

1381 (1.1)

429 (2.5)

221 (3.1)

122 (3.5)

55 (2.2)

16 (1.0)

1 (2.6)

< 0.0001

Diabetes mellitus

8179 (6.3)

12,865 (10.0)

3771 (21.9)

2217 (31.2)

1274 (36.9)

961 (38.4)

301 (19.1)

8 (21.1)

< 0.0001

SLE

738 (0.6)

409 (0.3)

58 (0.3)

29 (0.4)

27 (0.8)

31 (1.2)

23 (1.5)

0 (0.0)

< 0.0001

RA

802 (0.6)

674 (0.5)

94 (0.6)

41 (0.6)

22 (0.6)

15 (0.6)

8 (0.5)

0 (0.0)

0.1435

Polymyositis

70 (0.1)

28 (0.0)

3 (0.0)

2 (0.0)

2 (0.1)

1 (0.0)

0 (0.0)

0 (0.0)

NA

Dermatomyositis

73 (0.1)

47 (0.0)

1 (0.0)

1 (0.0)

2 (0.1)

0 (0.0)

0 (0.0)

0 (0.0)

NA

Transplant, others

130 (0.1)

204 (0.2)

86 (0.5)

41 (0.6)

17 (0.5)

6 (0.2)

6 (0.4)

2 (5.3)

< 0.0001

  1. Abbreviation: BMI Body mass index, CHF Congestive heart failure, CKD Chronic kidney disease, COPD Chronic obstructive pulmonary disease, eGFR Estimated glomerular filtration rate, GERD Gastroesophageal reflux disease, IPF Idiopathic pulmonary fibrosis, RA Rheumatoid arthritis, SLE Systemic lupus erythematosus
  2. The number means mean ± standard deviation and number (%)
  3. Chi-square tests for categorical variables; ANOVA for continuous variables